{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T15:03:05Z","timestamp":1771340585845,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02079-6","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:04:33Z","timestamp":1770883473000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and genetic insights into novel TP53 mutations in De Novo AML patients"],"prefix":"10.1007","volume":"26","author":[{"given":"Afia Muhammad","family":"Akram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sikandar","family":"Hayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Yousaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noreen","family":"Sarwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakina","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Yaqoob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amjad","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham M.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutwakel","family":"Dabiellil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malik Ihsan Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"1","key":"2079_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-01193-0","volume":"8","author":"Y Chen","year":"2022","unstructured":"Chen Y, Li J, Xu L, G\u0103man M-A, Zou Z. The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: from biology to therapeutic targeting. Cell Death Discov. 2022;8(1):397.","journal-title":"Cell Death Discov"},{"issue":"11","key":"2079_CR2","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1007\/s11864-022-01021-8","volume":"23","author":"S Chakraborty","year":"2022","unstructured":"Chakraborty S, Park CY. Pathogenic mechanisms in acute myeloid leukemia. Curr Treat Options Oncol. 2022;23(11):1522\u201334.","journal-title":"Curr Treat Options Oncol"},{"key":"2079_CR3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21871","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"2079_CR4","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/ejh.14404","volume":"114","author":"B Ghimire","year":"2025","unstructured":"Ghimire B, Zimmer M, Donthireddy V. TP53-mutated acute myeloid leukemia: review of treatment and challenges. Eur J Haematol. 2025;114(6):924\u201337.","journal-title":"Eur J Haematol"},{"issue":"1","key":"2079_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13045-015-0139-z","volume":"8","author":"CY Ok","year":"2015","unstructured":"Ok CY, Patel KP, Garcia-Manero G, Routbort MJ, Peng J, Tang G, Goswami M, Young KH, Singh R, Medeiros LJ, Kantarjian HM. TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases. J Hematol Oncol. 2015May 8;8(1):45.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"2079_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13041082","volume":"13","author":"C Stafylidis","year":"2024","unstructured":"Stafylidis C, Vlachopoulou D, Kontandreopoulou C-N, Diamantopoulos P\u03a4. Unmet horizons: assessing the challenges in the treatment of TP53-mutated acute myeloid leukemia. J Clin Med. 2024;13(4):1082.","journal-title":"J Clin Med"},{"issue":"19","key":"2079_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910782","volume":"22","author":"B George","year":"2021","unstructured":"George B, Kantarjian H, Baran N, Krocker JD, Rios A. TP53 in acute myeloid leukemia: molecular aspects and patterns of mutation. Int J Mol Sci. 2021;22(19):10782.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2079_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41568-020-0262-1","volume":"20","author":"AJ Levine","year":"2020","unstructured":"Levine AJ. P53: 800 million years of evolution and 40 years of discovery. Nat Rev Cancer. 2020;20(8):471\u201380.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2079_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/cdd.2017.180","volume":"25","author":"EH Baugh","year":"2018","unstructured":"Baugh EH, Ke H, Levine AJ, Bonneau RA, Chan CS. Why are there hotspot mutations in the TP53 gene in human cancers? Cell Death Differ. 2018;25(1):154\u201360.","journal-title":"Cell Death Differ"},{"issue":"2","key":"2079_CR10","volume":"1","author":"N Singh","year":"2016","unstructured":"Singh N, Upadhyay S, Jaiswar A, Mishra N. In silico analysis of protein. J Bioinform Genomics Proteom. 2016;1(2):1007.","journal-title":"J Bioinform Genomics Proteom"},{"key":"2079_CR11","first-page":"(baab012)","volume":"2021","author":"S Ramazi","year":"2021","unstructured":"Ramazi S, Zahiri J. Post-translational modifications in proteins: resources, tools and prediction methods. Database 2021. J Biol Databases Curation. 2021;2021:(baab012).","journal-title":"J Biol Databases Curation"},{"issue":"15","key":"2079_CR12","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1182\/blood.2021014472","volume":"139","author":"T Grob","year":"2022","unstructured":"Grob T, Al Hinai AS, Sanders MA, Kavelaars FG, Rijken M, Gradowska PL, et al. Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome. Blood. 2022;139(15):2347\u201354.","journal-title":"Blood"},{"issue":"4","key":"2079_CR13","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/hemato3040050","volume":"3","author":"F Zingarelli","year":"2022","unstructured":"Zingarelli F, Zannoni L, Curti A. TP53 mutant acute myeloid leukemia: the immune and metabolic perspective. Hemato. 2022;3(4):742\u201357.","journal-title":"Hemato"},{"key":"2079_CR14","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S265637","author":"EM Granowicz","year":"2022","unstructured":"Granowicz EM, Jonas BA. Targeting TP53-mutated acute myeloid leukemia: research and clinical developments. Onco Targets Ther. 2022 Apr 21;15:423-436. PMID: 35479302; PMCID:PMC9037178.https:\/\/doi.org\/10.2147\/OTT.S265637.","journal-title":"Onco Targets Ther.15:423-436. doi: 10.2147\/OTT.S265637. PMID: 35479302; PMCID: PMC9037178."},{"issue":"2","key":"2079_CR15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3324\/haematol.2022.280801","volume":"108","author":"S Kayser","year":"2023","unstructured":"Kayser S, Levis MJ. The clinical impact of the molecular landscape of acute myeloid leukemia. Haematologica. 2023;108(2):308.","journal-title":"Haematologica"},{"issue":"1","key":"2079_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13029-019-0075-3","volume":"14","author":"G Faure","year":"2019","unstructured":"Faure G, Joseph AP, Craveur P, Narwani TJ, Srinivasan N, Gelly J-C, et al. iPBAvizu: a PyMOL plugin for an efficient 3D protein structure superimposition approach. Source code for biology and medicine. 2019;14(1):1\u20135.","journal-title":"Source code for biology and medicine"},{"issue":"D1","key":"2079_CR17","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, Doncheva NT, Legeay M, Fang T, Bork P. The STRING database in 2021: customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49(D1):D605\u201312.","journal-title":"Nucleic Acids Res"},{"issue":"15","key":"2079_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22157845","volume":"22","author":"A Che\u0142kowska-Pauszek","year":"2021","unstructured":"Che\u0142kowska-Pauszek A, Kosi\u0144ski JG, Marciniak K, Wysocka M, B\u0105kowska-\u017bywicka K, \u017bywicki M. The role of RNA secondary structure in regulation of gene expression in bacteria. Int J Mol Sci. 2021;22(15):7845.","journal-title":"Int J Mol Sci"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02079-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02079-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02079-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T14:03:00Z","timestamp":1771336980000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02079-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2079"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02079-6","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"3 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Study was done in accordance with the principles of Declaration of Helsinki and was approved by ethics committee of Jinnah and Mayo Hospitals, Lahore. The written informed consent was obtained from all the participants and\/or their legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"149"}}